XML 70 R47.htm IDEA: XBRL DOCUMENT  v2.3.0.11
Acquisitions and Acquisition-Related Items (Details)
In Millions, except Per Share data, unless otherwise specified
12 Months Ended 0 Months Ended 1 Months Ended 0 Months Ended 1 Months Ended 12 Months Ended 1 Months Ended 12 Months Ended 0 Months Ended 1 Months Ended 3 Months Ended 1 Months Ended 3 Months Ended 1 Months Ended 1 Months Ended 3 Months Ended
Apr. 29, 2011
USD ($)
Apr. 30, 2010
USD ($)
Apr. 24, 2009
USD ($)
Feb. 25, 2011
Jolife [Member]
USD ($)
Jan. 13, 2011
Ardian Inc [Member]
USD ($)
Nov. 16, 2010
Osteotech [Member]
USD ($)
Aug. 12, 2010
ATS Medical [Member]
USD ($)
Jun. 30, 2010
Axon Surgical [Member]
USD ($)
Apr. 29, 2011
NeuroPace [Member]
USD ($)
Apr. 30, 2010
Invatec [Member]
USD ($)
Apr. 30, 2010
Invatec [Member]
USD ($)
Sep. 14, 2010
Cardio Vascular Acquiree [Member]
USD ($)
Aug. 31, 2009
Coronary Japan [Member]
USD ($)
Feb. 28, 2010
Arbor Surgical Technologies [Member]
USD ($)
Apr. 30, 2009
Core Valve [Member]
USD ($)
Feb. 28, 2009
Ablation Frontiers [Member]
USD ($)
Nov. 30, 2008
CryoCath Technologies [Member]
USD ($)
Nov. 30, 2008
CryoCath Technologies [Member]
CAD
Jul. 31, 2008
Restore Medical [Member]
Jul. 31, 2008
Restore Medical [Member]
USD ($)
Feb. 28, 2009
Ventor [Member]
USD ($)
Apr. 24, 2009
Spine And Diabetes I P [Member]
USD ($)
Business Acquisition [Line Items]                                            
Purchased in Process Research and Development Charges $ 44 $ 11 $ 621           $ 15   $ 12 $ 15   $ 11             $ 307 $ 22
Noncontrolling Interest, Ownership Percentage by Parent         11.30%                                  
Business Acquisition, Effective Date of Acquisition       2011-02-25 2011-01-13 2010-11-16 2010-08-12 2010-06-02   2010-04   2010-09-14 2009-08 2010-02 2009-04 2009-02 2008-11   2008-07   2009-02  
Finite-Lived Intangible Assets, Useful Life (in years) from three to 20 years     10 years 12 years nine years 11 years 10 years   12 years     five years   12 years 11 years 11 years   10 years      
Gain on Previously Held Investment         85                                  
Acquisition-related items 14 23 621   10 21 24                              
Purchase Accounting Liabilities                             39              
Business Acquisition, Purchase Price Allocation                                            
Current assets         12 34 51     77 77       20 7 24          
Property, plant and equipment         1 21 7     32 32       7 1 2          
IPR&D         191 1 6     114 114       123 97 72          
Other intangible assets       46 55 46 101 41   228 228   29   291 63 57     17    
Goodwill       18 807 19 209 16   161 161       424 107 184     5    
Inventory           41                                
Other long-term assets           3       1 1                      
Long-term deferred tax assets             34                   61          
Total assets acquired         1,066 165 408     613 613       865 275 400          
Current liabilities         10 19 14     46 46       65 19 30          
Other long-term liabilities           15                                
Long-term deferred tax liabilities         36 8       99 99       100 21 15          
Total liabilities assumed         46 42 14     145 145       165 40 45          
Net assets acquired         1,020 123 394     468 468       700 235 355          
Business Acquisition, Purchase Price Allocation, Notes Payable and Long-term Debt             30                              
Business Acquisition, Purchase Price Allocation, Tangible Assets           57 78 5                       8    
Business Acquisition, Purchase Price Allocation, Net Tangible Liabilities       11 33                                  
Business Acquisition, Contingent Consideration                                            
Business Acquisition, Contingent Consideration, Potential Cash Payment 240           10     150 150 10                    
Business Acquisition, Contingent Consideration, Potential Cash Payment Revenue Milestone                   75 75                      
Business Acquisition, Contingent Consideration, Potential Cash Payment Product Development Milestone                   75 75                      
Business Acquisition, Contingent Consideration, at Fair Value 335 118     212         118 118 6                    
Business Acquisition, Cost of Acquired Entity                                            
Business Acquisition, Cost of Acquired Entity, Cash Paid         717         350 350 15     700 225            
Business Acquisition, Cost of Acquired Entity, Purchase Price       53 1,020 123 394 62                            
Acquisition, Purchase Price Per Share           $ 6.50 $ 4.00                     8.75   $ 1.60    
Estimated Total Costs to Complete IPRD         50                   80 3 3          
Acquisition, Total Value of Transaction                   468 468 21       235            
Acquisition, Net Value of Transaction                                 $ 352     $ 29 $ 308